Practice Point®: Rare Diseases

Episode 30 - Days 3 and 4: Key Breakthroughs from EASL 2026

These podcast episodes explore the rapidly evolving treatment landscape of Primary Biliary Cholangitis, highlighting recent therapeutic advances and reviews emerging clinical evidence on promising investigational therapies. Designed for healthcare professionals, these episodes provides expert commentary on the latest cutting-edge data presented at EASL Congress 2026. Through an engaging podcast format, listeners will gain practical insights into how new evidence can inform personalized treatment strategies, support improved patient outcomes, and enhance the overall quality of care for people living with PBC. Launch Date/Release: June 3, 2026 Expiration Date: May 31, 2027 FACULTY Kris V. Kowdley, MD, AGAF, FAASLD, FACG, FACP Liver Institute Northwest Director, Velocity Clinical Research Medical Director and Senior Scientific Advisor Washington State University Elson S. Floyd College of Medicine – Professor This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link [https://www.practicepointcme.com/CMEHome/pbc-podcast-key-breakthroughs-from-easl-2026] prior to listening to this podcast.

Episode 29 - Days 1 and 2: Key Breakthroughs from EASL 2026

These podcast episodes explore the rapidly evolving treatment landscape of Primary Biliary Cholangitis, highlighting recent therapeutic advances and reviews emerging clinical evidence on promising investigational therapies. Designed for healthcare professionals, these episodes provides expert commentary on the latest cutting-edge data presented at EASL Congress 2026. Through an engaging podcast format, listeners will gain practical insights into how new evidence can inform personalized treatment strategies, support improved patient outcomes, and enhance the overall quality of care for people living with PBC. Launch Date/Release: June 3, 2026 Expiration Date: May 31, 2027 FACULTY Kris V. Kowdley, MD, AGAF, FAASLD, FACG, FACP Liver Institute Northwest Director, Velocity Clinical Research Medical Director and Senior Scientific Advisor Washington State University Elson S. Floyd College of Medicine – Professor This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link [https://www.practicepointcme.com/CMEHome/pbc-podcast-key-breakthroughs-from-easl-2026] prior to listening to this podcast.

Episode 28 - NF1-PN Podcast: Key Advances from AAN 2026

Leveraging emerging evidence presented at AAN, Dr. Angela Hirbe provides synthesis of key findings, highlight their relevance across pediatric and adult care, and frame practical considerations for patient assessment and longitudinal management. Launch/Release Date: April 24, 2026 Activity Expiration Date: March 31, 2027 FACULTY Angela Hirbe, MD, PhD Associate Professor of Medicine and Pediatrics Director, Adult Neurofibromatosis Clinical Program Division of Oncology, Sarcoma Section Washington University School of Medicine St. Louis, Missouri This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link [https://www.practicepointcme.com/CMEHome/nf1-pn-podcast-key-advances-from-aan-2026] prior to listening to this podcast.

Episode 27 - MG Podcast: Emerging Insights from AAN 2026

Clinical care for myasthenia gravis is entering a period of meaningful progress, with growing opportunities to improve how the disease is diagnosed, assessed, and treated. Increased awareness of disease heterogeneity and the expanding use of standardized severity assessments are helping clinicians better define disease burden and guide management decisions. [http://decisions.In] In [http://decisions.In] this 20-minute podcast episode, Dr. James Howard Jr. provides comprehensive coverage of key MG presentations, scientific symposia, posters, and abstracts presented at AAN 2026. Launch/Release Date: April 23, 2026 Activity Expiration Date: March 31, 2027 FACULTY James F. Howard, Jr., MD, FAAN Professor of Neurology, Medicine & Allied Health Director, Myasthenia Gravis Clinical Trials and Translational Research Program The University of North Carolina at Chapel Hill This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link [https://www.practicepointcme.com/CMEHome/mg-podcast-emerging-insights-from-aan-2026] prior to listening to this podcast.

Episode 26 - Patient-Focused Strategies to Effectively Diagnose, Treat, and Manage NF1-PN

This activity will provide a comprehensive overview of NF1-PN and will dive deeper into the nuances of treating and managing adult patients with inoperable symptomatic NF1-PN. Dr. Angela Hirbe will use clinical cases to illustrate best-practice approaches to optimally identify adult patients with NF1-PN that will benefit from approved MEK inhibitors and will detail how to choose between agents and address/prevent adverse effects. The work-up and monitoring recommendations will also be discussed and any insights for achieving improved outcomes among diverse patients will be detailed. This presentation will empower participants to make informed clinical decisions for different patients with distinct needs. Launch/Release Date: October 16, 2025 Activity Expiration Date: September 30, 2026 FACULTY Angela Hirbe, MD, PhD Associate Professor of Medicine and Pediatrics Director Adult Neurofibromatosis Clinical Program Division of Oncology Sarcoma Section Washington University School of Medicine St. Louis, Missouri This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link [https://www.practicepointcme.com/CMEHome/patient-focused-strategies-to-effectively-diagnose-treat-and-manage-nf1-pn-1] prior to listening to this podcast.